drugset / Trial / NCT02275962

Drug-Drug Interaction Study in Healthy Adult Volunteers

NCT02275962 ↗

Phase 1 Completed 20 enrolled Kowa Research Institute, Inc.
Non-randomizedSingle-groupOpen-label

Summary

The purpose of this study is to assess the effects of rifampin on the pharmacokinetics of K-877 in healthy adult volunteers.

Timeline

Start
2014-09
Primary completion
2014-10
Completion
2015-05

Drugs

EvaluationDrugModalityDoseRoute
Subject K-877 Unknown — —
Subject Rifampicin Small molecule — —

Indications

No indication recorded.